Design and evaluation of polylactic-CO-Glycolic acid nanoparticles containing simvastatin

International Journal of Drug Development and Research

Volumn 3, Issue 2, 2011, Pages 280-289

  Shinde, Anilkumar J ^a   More, Harinath N ^a  

^a Bharati Vidhyapeeth College of Pharmacy   (India)

Author keywords

32 factorial design; Pleuronic F 68; PLGA; Simvastatin; Sustained release

Indexed keywords

EXCIPIENT; NANOPARTICLE; POLOXAMER; POLYGLACTIN; SIMVASTATIN; SOLVENT; STABILIZING AGENT;

ARTICLE; CIRCULATION; CONCENTRATION (PARAMETERS); DRUG BIOAVAILABILITY; DRUG DESIGN; DRUG DIFFUSION; DRUG FORMULATION; DRUG PENETRATION; DRUG SCREENING; DRUG SOLUBILITY; DRUG STABILITY; FACTORIAL DESIGN; FIRST PASS EFFECT; IN VITRO STUDY; LIVER METABOLISM; PARTICLE SIZE; PRECIPITATION; PRECIPITATION SOLVENT DEPOSITION; PROCESS OPTIMIZATION; SOLVENT EFFECT; SUSTAINED DRUG RELEASE; TRANSPORT KINETICS;

EID: 83055174079     PISSN: None     EISSN: 09759344     Source Type: Journal    
DOI: None     Document Type: Article

References (23)

1. E. Allemann, J.-C. Leroux, and R. Gurny. Polymeric nano- and microparticles for the oral delivery of peptides and peptidomimetics. Adv. Drug Deliv. Rev. 1998, 34:171-189.
2. M. L. Hans and A. M. Lowman. Biodegradable nanoparticles for drug delivery and targeting. Curr. Opin. Solid State Mater. Sci., 2002, 6:319-327.
3. S. S. Feng, L. Mu, K. Y. Win, and G. Huang. Nanoparticles of biodegradable polymers for clinical administration of paclitaxel. Curr. Med. Chem., 2004,11:413-424.
4. H. Murakami, Y. Kawashima, T. Niwa, T. Hino, and H. Takeuchi et al. Influence of the degrees of hydrolyzation and polymerization of poly(vinylalcohol) on the preparation and properties of poly(-lactide-coglycolide) nanoparticles. Int. J. Pharm., 1997,149:43-49.
5. H. Fessi, F. Puisieux, J.P. Devissaguet, N. Ammoury, Nano-capsule formation by interfacial deposition following solvent dis-placement. Int J Pharm.1989;55:R1-R4.
6. J.M. Barichello, M. Morishita, K. Takayama, T. Nagai. Encapsulation of hydrophilic and lipophilic drugs in PLGA nanoparticles by the nanoprecipitation method. Drug Dev Ind Pharm. 1999;25(4):471-476.
7. R. A. Jain. The manufacturing techniques of various drug loaded biodegradable poly(lactide-co-glycolide) (PLGA) devices. Biomaterials, 2000, 21: 2475-2490.
8. D.L. Wise, T.D. Fellmann, J.E. Sanderson, R.L. Wentworth. Lac-tic/glycolic acid polymers. In: Gregoridas G, ed. Drug Carriers in Biology and Medicine. London, UK: Academic Press; 1979:237-270.
9. E. Cauchetier, M. Deniau, H. Fessi, A. Astier, A. Paul. Atovaquone-loaded nanocapsules: influence of the polymer on their in vitro charac-teristics. Int J Pharm., 2003;250:273-281.
10. G. Claudia, B. Claudio, M. Adriana, P. Donatella, M.A. Vandelli, P. Giovanni, Influence of Preparation Conditions on Acyclovir-Loaded Poly-d,l-Lactic Acid Nanospheres and Effect of PEG Coating on Ocular Drug Bioavailability. Pharma. Research. 2003, 20, 4.
11. Ashish K. Mehta, K.S. Yadav, Krutika K. Sawant Nimodipine Loaded PLGA Nanoparticles: Formulation Optimization Using Factorial Design, Characterization and In Vitro Evaluation. Current Drug Delivery, 2007, 4,185-193
12. A. Rawle (Malvern Instruments Limited, Enigma business park, Grovewood Road, Malvern, Worcestershire, UK). Basic principles of particle size analysis. Technical paper. Malvern Instruments; Report No.: MRK034.
13. E. Allemann, R.G. Leroux. Biodegradable nanoparticles of particles of poly(lactic acid) and poly(lactic-co-glycolic acid) for parenteral administration. In: Gregoridas G, ed. Pharmaceutical Dosage Form. New York, NY: Marcel Dekker; 1999:163-186.
14. M.J. Alonso. Nanoparticulate drug carrier technology. In: Microparticulate systems for the delivery of proteins and vaccines. New York: Marcel Dekker; 1996., 203-242.
15. G. Stetsko, Statistical experimental design and its application to pharmaceutical development problems. Drug Dev Ind Pharm. 1986;12:1109-1123.
16. E. Allemann, R. Gumy, E. Doelker, Drug loaded nanoparticles preparation methods and drug targeting tissues. Eur.J.Pharm. Biopharm. 1993, 39,173-191.
17. M.F. Chothy, J. Danenberg et.al; Lipophillic drug loaded nanospheres prepared by Nanoprecipitation technique: effect of formulation variables on size, drug delivery and release kinetics. J. Control. Release, 2002, 83, 389-400.
18. R. Gurny, N.A Peppas, D.D. Harrington, G.S. Banker, Development of biodegradable and injectable latices for controlled release of potent drugs. Drug Development and Industrial Pharmacy 1981; 7:1-25.
19. S. Magdassi and G.K Margulis: Formation of simvastatin nanoparticles from microemulsion. Nanotechnology Biology and Medicine in Nanomedicine. 2009; 5: 274-281.
20. N. Arunkumar, M. Deecaraman, C. Rani, K.P. Mohanraj, K. Venkateskumar: Preparation and solid state characterization of atorvastatin nanosuspensions for enhanced solubility and dissolution. International Journal of PharmTech Research 2009;1: 1725-1730.
21. P. Kocbek, S. Baumgartner, J. Kristi: Preparation and evaluation of nanosuspensions for enhancing dissolution of poorly soluble drugs. International Journal of Pharmaceutics, 2006; 312(1-2):179-186.
22. A.A. Zaghloul, S.R. Vaithiyalingam, J. Faltinek, I.K. Reddy, M.A. Khan. Response surface methodology to obtain naproxen controlled release tablets from its microspheres with Eudragit L 100-55. J Micro-encapsul. 2001;18(5):651-662
23. V.S. Labhastwar, R.J. Levy: Nanoparticle drug delivery systems. Adv.drug delivery.Rev., 1997, 24, 63-85.